Sriven Pharmachem India Private Limited, a active private limited company, was established on 05 March 2015 in Tirumalagiri, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24233TG2015PTC097894. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹31.00 Cr and a paid-up capital of ₹30.46 Cr.
It upholds a compliant status. Employing 79 professional, Its leadership includes Suryanarayana Raju Rudraraju (Director), Krishnaveni Rudraraju (Director), Raj Thirmal Mekamalla (Additional Director). Past directors included Padmanabha Raju Chekuri, Mantena Kumar Naveen, Ramaraju Kanumuri. It holds ₹44.96 Cr open charges and ₹1.75 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H. No. 1-2-33/15, Plot No. 15 & 16, Flat No. 101,, A S R Raju Nagar, Road No. 1, Nizampet Road,, Tirumalagiri, Telangana, 500085.
U24233TG2015PTC097894
097894
05 March 2015
₹31.00 Cr
₹30.46 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sriven Pharmachem India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suryanarayana Raju Rudraraju | Director | 05 Mar 2015 | Current |
| Krishnaveni Rudraraju | Director | 08 Dec 2022 | Current |
| Raj Thirmal Mekamalla | Additional Director | 21 Feb 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Aug 2017 | Past |
| Pramod Abcsdd | Director | 28 Dec 2019 | Past |
| Pramod Abcsdd | Director | 22 Jun 2020 | Past |
| Pramod Abcsdd | Director | 06 Jan 2017 | Past |
| Pramod Abcsdd | Director | 11 Aug 2017 | Past |
| Pramod Abcsdd | Director | 06 Jan 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sriven Pharmachem India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 112.69% increase. The company also saw a substantial improvement in profitability, with a 67.51% increase in profit. The company's net worth Soared by an impressive increase of 62.33%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sriven Pharmachem India had a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹449,640,001.00
₹17,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Sep 2025 | Canara Bank | ₹1.40 Cr | Open |
| 14 Aug 2024 | Hdfc Bank Limited | ₹0.99 M | Open |
| 26 Jul 2024 | Hdfc Bank Limited | ₹1.15 M | Open |
| 16 Jul 2024 | Others | ₹1.01 M | Open |
| 12 Apr 2024 | Others | ₹1.51 M | Open |
Explore comprehensive loan charge details -
Sriven Pharmachem India has a workforce of 79 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sriven Pharmachem India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sriven Pharmachem India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Canara Bank amounted to Rs. 1.40 Cr with Charge ID 101174560 was registered on 22 Sep 2025. was documented.
Progress on Priyanka Gaur was appointed as a Company Secretary was appointed as a Company Secretary on 20 Jun 2025 & has been associated with this company since 5 months 15 days . was documented.
The activity Raj Thirmal Mekamalla was appointed as a Additional Director was appointed as a Additional Director on 21 Feb 2025 & has been associated with this company since 9 months 12 days . was completed.
A charge with Hdfc Bank Limited of Rs. 40.90 Cr registered on 23 May 2022 with Charge ID 100578906 was modified on 27 Nov 2024. was recorded as a recent event.
The activity Sriven Pharmachem India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.10 Cr with Charge ID 100997275 was registered on 14 Aug 2024. was documented.
The CIN of Sriven Pharmachem India Private Limited is U24233TG2015PTC097894.
Sriven Pharmachem India Private Limited is headquartered at H. No. 1-2-33/15, Plot No. 15 & 16, Flat No. 101,, A S R Raju Nagar, Road No. 1, Nizampet Road,, Tirumalagiri, Telangana, 500085.
Sriven Pharmachem India Private Limited was incorporated on 05 March 2015.
The current directors of Sriven Pharmachem India Private Limited are
The primary industry of Sriven Pharmachem India Private Limited is Manufacturing.
Sriven Pharmachem India Private Limited is unlisted.
The authorized capital of Sriven Pharmachem India Private Limited is ₹31.00 Cr, and the paid-up capital is ₹30.46 Cr.
The compliance status of Sriven Pharmachem India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX